Most recent by Larry B. Goldstein, MD, FAAN, FANA, FAHA
Inaccurate aspirin allergy labels increase odds for poor stroke outcomes
Patients with stroke and inaccurate NSAID allergy labels had poorer outcomes including major adverse cardiovascular events, peripheral vascular disease and death, according to a study published in Stroke.
Tiny plastics in carotid plaque tied to elevated risk for heart attack, stroke, death
Among patients with asymptomatic carotid artery disease who had carotid endarterectomy, those whose atheromas contained microplastics and/or nanoplastics had worse outcomes than those whose atheromas did not, researchers reported.
Intensive BP control harmful after endovascular thrombectomy for acute ischemic stroke
In patients who had endovascular thrombectomy for acute ischemic stroke with large-vessel occlusion, intensive systolic BP control to less than 120 mm Hg was linked with poor outcomes after the procedure, researchers reported.
DOACs safer than warfarin in patients with cerebral venous thrombosis
In patients with cerebral venous thrombosis, direct oral anticoagulants were safer than warfarin without compromising efficacy, researchers reported at the International Stroke Conference.
EVT improves outcomes in large vessel occlusion with large cerebral infarction
Endovascular therapy for patients with acute large vessel occlusion with large ischemic core improved their likelihood of achieving a favorable outcome at 90 days by more than twofold vs. medical therapy alone, a speaker reported.
Ticagrelor gains FDA approval for secondary stroke prevention
AstraZeneca announced the FDA approved its P2Y12 inhibitor ticagrelor for the reduction of stroke risk among patients with acute ischemic stroke or high-risk transient ischemic attack.